These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1597212)

  • 21. In-vitro susceptibility of Helicobacter pylori to ampicillin, clarithromycin, metronidazole and omeprazole.
    Loo VG; Fallone CA; De Souza E; Lavallée J; Barkun AN
    J Antimicrob Chemother; 1997 Dec; 40(6):881-3. PubMed ID: 9462442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of a catechol-O-methyltransferase inhibitor, nitecapone, in human plasma and urine by liquid chromatography.
    Wikberg T; Taskinen J
    J Pharm Biomed Anal; 1991; 9(1):59-64. PubMed ID: 2043724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat.
    Nissinen E; Lindén IB; Schultz E; Kaakkola S; Männistö PT; Pohto P
    Eur J Pharmacol; 1988 Aug; 153(2-3):263-9. PubMed ID: 3181288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The susceptibility of Helicobacter pylori to 12 antimicrobial agents, omeprazole and bismuth salts.
    Rubinstein G; Dunkin K; Howard AJ
    J Antimicrob Chemother; 1994 Sep; 34(3):409-13. PubMed ID: 7829415
    [No Abstract]   [Full Text] [Related]  

  • 25. Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori.
    Gatta L; Perna F; Figura N; Ricci C; Holton J; D'Anna L; Miglioli M; Vaira D
    J Antimicrob Chemother; 2003 Feb; 51(2):439-42. PubMed ID: 12562719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitecapone effect on the synthesis and secretion of gastric sulfomucin.
    Slomiany BL; Liau YH; Lopez RA; Slomiany A
    Gen Pharmacol; 1993 Jan; 24(1):69-73. PubMed ID: 8387047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of NF-kappa B transcription factor by catechol derivatives.
    Suzuki YJ; Packer L
    Biochem Mol Biol Int; 1994 Feb; 32(2):299-305. PubMed ID: 8019435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Graphical analysis of 6-fluoro-L-dopa trapping: effect of inhibition of catechol-O-methyltransferase.
    Holden JE; Doudet D; Endres CJ; Chan GL; Morrison KS; Vingerhoets FJ; Snow BJ; Pate BD; Sossi V; Buckley KR; Ruth TJ
    J Nucl Med; 1997 Oct; 38(10):1568-74. PubMed ID: 9379194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitecapone reduces development and symptoms of neuropathic pain after spinal nerve ligation in rats.
    Kambur O; Männistö PT; Pusa AM; Käenmäki M; Kalso EA; Kontinen VK
    Eur J Pain; 2011 Aug; 15(7):732-40. PubMed ID: 21216640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolite profiles of two [14C]-labelled catechol O-methyltransferase inhibitors, nitecapone and entacapone, in rat and mouse urine and rat bile.
    Wikberg T; Vuorela A
    Eur J Drug Metab Pharmacokinet; 1994; 19(2):125-35. PubMed ID: 8001593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of catechol-O-methyltransferase inhibition on brain uptake of [18F]fluorodopa: implications for compartmental modelling and clinical usefulness.
    Léger G; Gjedde A; Kuwabara H; Guttman M; Cumming P
    Synapse; 1998 Dec; 30(4):351-61. PubMed ID: 9826227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The susceptibility of Helicobacter pylori to the rifamycin, rifaximin.
    Holton J; Vaira D; Menegatti M; Barbara L
    J Antimicrob Chemother; 1995 Apr; 35(4):545-9. PubMed ID: 7628989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of lansoprazole against Helicobacter pylori.
    Megraud F; Boyanova L; Lamouliatte H
    Lancet; 1991 Jun; 337(8755):1486. PubMed ID: 1675355
    [No Abstract]   [Full Text] [Related]  

  • 34. The equine metabolism of the catechol-O-methyltransferase enzyme inhibitor nitecapone.
    Stanley S; Deng D; Van den Berg K; Foo HC
    Drug Test Anal; 2022 May; 14(5):929-935. PubMed ID: 34545698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of COMT induces dopamine-dependent natriuresis and inhibition of proximal tubular Na+,K+-ATPase.
    Eklöf AC; Holtbäck U; Sundelöf M; Chen S; Aperia A
    Kidney Int; 1997 Sep; 52(3):742-7. PubMed ID: 9291195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitecapone: a nitric oxide radical scavenger.
    Marcocci L; Maguire JJ; Packer L
    Biochem Mol Biol Int; 1994 Oct; 34(3):531-41. PubMed ID: 7833830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omeprazole inhibits growth of gram-positive and gram-negative bacteria including Helicobacter pylori in vitro.
    Jonkers D; Stobberingh E; Stockbrügger R
    J Antimicrob Chemother; 1996 Jan; 37(1):145-50. PubMed ID: 8647756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bactericidal activity of lansoprazole and omeprazole against Helicobacter pylori in vitro.
    Vogt K; Hahn H
    Arzneimittelforschung; 1998 Jun; 48(6):694-7. PubMed ID: 9689430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibacterial effect of garlic and omeprazole on Helicobacter pylori.
    Jonkers D; van den Broek E; van Dooren I; Thijs C; Dorant E; Hageman G; Stobberingh E
    J Antimicrob Chemother; 1999 Jun; 43(6):837-9. PubMed ID: 10404325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antioxidant properties of nitecapone are potentiated by glutathione.
    Nissinen E; Lindén IB; Pohto P
    Biochem Mol Biol Int; 1995 Feb; 35(2):387-95. PubMed ID: 7663394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.